A novel therapeutic target, GPR43; where it stands in drug discovery.
SCIE
SCOPUS
KCI
- Title
- A novel therapeutic target, GPR43; where it stands in drug discovery.
- Authors
- Kim, S; Kim, YM; Kwak, YS
- Date Issued
- 2012-09
- Publisher
- Pharmaceutical Society of Korea
- Abstract
- With growing interest in human microbiome for its implication in metabolic disorders, inflammatory diseases, immune disorders and so forth, understanding the biology at the interface of the gut flora and the host becomes very important for identifying novel therapeutic avenues. GPR43 has been deorphanized and the metabolites of microbiome, such as short-chain fatty acids, serve as its natural ligands. There are numerous reports that GPR43 might be a crucial link to the novel therapies for the unmet medical needs and many drug discovery organizations are making their moves in response.
- Keywords
- PROTEIN-COUPLED RECEPTOR; CHAIN FATTY-ACIDS; GUT MICROBIOTA; FUNCTIONAL-CHARACTERIZATION; IDENTIFICATION; CANCER; INFLAMMATION; PROPIONATE; ACTIVATION; EXPRESSION
- URI
- https://oasis.postech.ac.kr/handle/2014.oak/15907
- DOI
- 10.1007/s12272-012-0900-6
- ISSN
- 0253-6269
- Article Type
- Article
- Citation
- Archives of Pharmacal Research, vol. 35, no. 9, page. 1505 - 1509, 2012-09
- Files in This Item:
- There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.